SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001842952-24-000019
Filing Date
2024-03-22
Accepted
2024-03-22 08:04:35
Documents
1
Period of Report
2024-03-21

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1711109066.html 4  
1 FORM 4 wk-form4_1711109066.xml 4 4072
  Complete submission text file 0001842952-24-000019.txt   5634
Mailing Address 2001 MARKET STREET SUITE 3915 UNIT #15 PHILADELPHIA PA 19103
Business Address 2001 MARKET STREET SUITE 3915 UNIT #15 PHILADELPHIA PA 19103 267-225-7416
Context Therapeutics Inc. (Issuer) CIK: 0001842952 (see all company filings)

IRS No.: 863738787 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 110 MILLER AVENUE SUITE 100 ANN ARBOR MI 48104
Business Address
Minai-Azary Jennifer Lynn (Reporting) CIK: 0001844398 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40654 | Film No.: 24773145